ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,165Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 783

$1.02M Total Retail Price of All Prescriptions

Rank: 48 out of 783

671 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 671 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 671 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 12,692 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 1,020 720 1 1
AMLODIPINE BESYLATE 689 559 2 5
LISINOPRIL 585 347 3 4
SIMVASTATIN 527 372 4 3
OMEPRAZOLE 518 313 5 6
GLIMEPIRIDE 426 232 6 34
PRAVASTATIN SODIUM 413 272 7 14
LOVASTATIN 381 285 8 58
CARVEDILOL 372 280 9 21
LOSARTAN POTASSIUM 368 265 10 18
FUROSEMIDE 299 223 11 7
FENOFIBRATE 297 217 12 66
HYDROCODONE-ACETAMINOPHEN 292 199 S3 13 2
METFORMIN HCL 279 158 14 8
METFORMIN HCL ER 271 165 15 64
METOPROLOL SUCCINATE 261 134 16 13
CITALOPRAM HBR 244 176 17 19
METOPROLOL TARTRATE 234 165 18 9
PANTOPRAZOLE SODIUM 217 120 19 30
CLOPIDOGREL 211 170 20 29
SERTRALINE HCL 206 161 21 22
CLONIDINE HCL 190 116 22 60
HYDROCHLOROTHIAZIDE 189 165 23 12
CHLORTHALIDONE 189 136 23 143
ATORVASTATIN CALCIUM 183 130 25 11
FLUTICASONE PROPIONATE 173 117 26 46
GABAPENTIN 171 104 27 15
TRILIPIX 168 66 28 192
SYNTHROID 167 142 29 47
QUINAPRIL HCL 165 114 30 195
PLAVIX 157 128 31 51
NAMENDA 149 130 32 32
ALLOPURINOL 148 108 33 31
BISOPROLOL-HYDROCHLOROTHIAZIDE 143 103 34 154
WARFARIN SODIUM 141 106 35 10
NEXIUM 141 85 35 28
POLYETHYLENE GLYCOL 3350 138 108 37 43
FAMOTIDINE 136 63 38 55
JANUVIA 135 52 39 73
TRAMADOL HCL 129 107 40 20
BENAZEPRIL HCL 128 81 41 85
DONEPEZIL HCL 128 105 41 24
AZITHROMYCIN 127 97 43 41
CEPHALEXIN 118 85 44 70
ZETIA 118 84 44 80
KLOR-CON M20 115 69 46 48
LANTUS SOLOSTAR 113 54 47 91
TAMSULOSIN HCL 113 93 47 26
DILTIAZEM HCL 112 87 49 207
CRESTOR 109 68 50 27
LANTUS 108 82 51 38
POTASSIUM CHLORIDE 105 83 52 16
ISOSORBIDE MONONITRATE ER 104 68 53 40
DIOVAN 100 75 54 49
ALENDRONATE SODIUM 97 85 55 25
CYMBALTA 93 46 56 35
MIDODRINE HCL 93 49 56 289
SPIRONOLACTONE 89 56 58 57
BYSTOLIC 89 72 58 99
NIFEDIPINE ER 87 64 60 135
LIOTHYRONINE SODIUM 87 47 60 269
AMLODIPINE BESYLATE-BENAZEPRIL 86 51 62 83
PROAIR HFA 83 38 63 56
SPIRIVA 83 64 63 59
PROPRANOLOL HCL 80 51 65 129
SINGULAIR 74 31 66 90
CIPROFLOXACIN HCL 73 52 67 62
AMITRIPTYLINE HCL 73 36 R 67 77
TORSEMIDE 73 38 67 126
LEVOCETIRIZINE DIHYDROCHLORIDE 72 36 70 322
BENICAR 69 57 71 182
KLOR-CON 10 69 45 71 102
BUMETANIDE 68 40 73 131
PEN NEEDLE 68 37 73 103
DICLOFENAC SODIUM 67 42 75 139
ZOLPIDEM TARTRATE 67 38 75 23
ROPINIROLE HCL 66 27 77 74
VENTOLIN HFA 64 17 78 159
LISINOPRIL-HYDROCHLOROTHIAZIDE 64 37 78 33
METHYLPREDNISOLONE 63 42 80 138
LOSARTAN-HYDROCHLOROTHIAZIDE 63 42 80 53
RANITIDINE HCL 62 21 82 44
ADVAIR DISKUS 62 51 82 50
MELOXICAM 62 14 82 37
EXELON 61 61 85 109
HUMALOG 59 34 86 101
NIASPAN 56 0 87 140
AMOXICILLIN 55 35 88 116
RAMIPRIL 54 24 89 113
FOSINOPRIL SODIUM 53 38 90 258
TRICOR 52 18 91 134
MONTELUKAST SODIUM 52 27 91 160
INSULIN SYRINGE 52 35 91 82
CYCLOBENZAPRINE HCL 51 27 R 94 63
TRAZODONE HCL 51 20 94 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.